Skip to main content

HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain

The DEA is not bound to follow the U.S. Health and Human Services Department's recommendation to reclassify marijuana as a Schedule III drug.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.